Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-24 @ 9:12 PM
NCT ID:
NCT00767104
Eligibility Criteria:
Inclusion Criteria:
* Male or female with facial acne vulgaris, 12 years of age or older, that agree to participate and provide written consent
* Greater than 5 superficial inflammatory lesions with less than 3 nodules on the face
* A score of 2-4 on the Investigator Global Assessment
* Women of childbearing potential will be allowed to participate in the study, and these subjects will be required to use at least one form of birth control
* Female subjects will have a urine pregnancy test if applicable.
Exclusion Criteria:
* Use within 4 weeks of baseline of systemic anti-inflammatory medication, which may influence study outcome, such as systemic corticosteroids
* Application or use within 2 weeks of baseline of topical acne or rosacea medications or topical anti-inflammatory medication, which may influence study outcome
* Presence of a concurrent medical condition, which is determined by the investigator to potentially interfere with study outcomes or patient assessments
* Subjects who have taken isotretinoin within the past 6 months
* Subjects with known allergy or sensitivity to polyester or nylon fibers in fabric
* Pregnant women and women who are breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT00767104
Study Brief:
Protocol Section:
NCT00767104